We know every decision made in cGMP manufacturing affects the end patient. Therefore, we employ robust pharmaceutical-grade purification strategies (IEX/SEC/TTF) and always adhere to international standards and guidelines when available. This results in recombinant proteins with exceptional characterization, purity, and lot-to-lot consistency.
With first-in-industry FDA eCTD Master Files covering our leading cytokines & growth factors, we have a proven track record of prioritizing our customers' regulatory requirements to simplify their drug approval process. Akron’s knowledgeable product, quality, and regulatory groups are committed to your therapy’s success.


We continuously optimize and improve our ancillary materials to increase safety, consistency, and efficacy. In 2022 we launched our Closed System Solutions(CSS)® line of cGMP products, a line of cytokines and media supplements in single-use bags. The CSS line promises to reduce human error while increasing safety and consistency.